Medi Caps Ltd
BSE:MEDICAPQStandalone figures
| Ratio | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin % | — | — | — | — | ||||
Standalone figures
| Ratio | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin % | — | — | — | — | ||||
| — |
| — |
| — |
| — |
| EBITDA margin % | 4.9% | 5.3% | 3.6% | -74.1% | — | -300% | 67.5% | -4.6% |
| EBIT margin % | 4.9% | 5.3% | 2% | -77.3% | — | -390% | 65.3% | -11.2% |
| PAT margin % | 5% | 2.4% | 2.6% | -72.8% | — | 150% | 54.3% | 23.1% |
| Working capital | ||||||||
| Receivable days | — | — | — | — | — | 8,176 | 237 | 552 |
| Inventory days | — | — | — | — | — | 0 | 5 | 4 |
| Payable days | — | — | — | — | — | 0 | 2 | 6 |
| NWC days | — | — | — | — | — | 8,176 | 240 | 551 |
| Leverage | ||||||||
| Current ratio | — | — | — | — | — | 190 | 18.7 | 81.11 |
| Debt to EBITDA | — | — | — | — | — | — | 0 | — |
| Debt to equity | — | — | — | — | — | 0 | 0 | 0 |
| Interest coverage | — | — | 73 | -887 | — | — | — | — |
| Asset turnover | — | — | — | — | — | 0 | 0.11 | 0.04 |
| Return ratios | ||||||||
| Return on assets % | — | — | — | — | — | 0.2% | 5.7% | 0.8% |
| Return on capital employed % | — | — | — | — | — | 0.4% | 7.5% | 0.4% |
| Return on equity % | — | — | — | — | — | 0.2% | 5.9% | 0.8% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.